AL2846 capsule

DRUG3 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Advanced Lung CancerDifferentiated Thyroid CancerOvarian CancerSolid Tumor

Phase 1

Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer

CompletedNCT05745363

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Differentiated Thyroid Cancer

Start: 2023-02-24End: 2025-11-13Updated: 2025-12-16

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Solid Tumor

Start: 2022-09-02End: 2023-12-31Target: 135Updated: 2023-11-03

Phase 2

Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer

CompletedNCT05815862

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Advanced Lung Cancer, Ovarian Cancer

Start: 2023-02-15End: 2025-08-20Updated: 2025-08-29